CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma
(Q33732597)
scientific article published on March 2, 2010
scientific article published on March 2, 2010
Language:
Current Data About
CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma